Shaunak Deepak joins H.C. Wainwright

Shaunak Deepak has joined H.C. Wainwright as a managing director and senior biotechnology analyst in the firm’s equity research group.

Mr. Deepak previously was a VP and biotech analyst with Jefferies since 2009. He also has been an associate in the life sciences equity research departments of Piper Jaffray, Rodman & Renshaw and Stifel, Nicolaus.

In a statement, CEO, Mark Viklund, said Mr. Deepak’s addition as HCW’s eighth senior biotech analyst further strengthens the firm’s position as a leading voice in the investment community on the life sciences sector.

Sign up for the BioTuesdays weekly newsletter

Get the latest news on the healthcare industry’s corporate and clinical developments, executive moves, and market updates. Every Tuesday, in your inbox.